Public Health

CDC HEALTH ADVISORY: Influenza

Seasonal Influenza A(H3N2) Activity and Antiviral Treatment of Patients with Influenza Summary The Centers for Disease Control and Prevention (CDC) is providing: a notice about increased influenza A(H3N2) activity and its clinical implications; a summary of influenza antiviral drug treatment recommendations; an update about approved treatment drugs and…

Read More

ADH adopts new guidelines for high blood pressure

Hypertension (high blood pressure) is one of the primary causes of heart attack and stroke. Arkansas leads the nation for the highest heart attack death rates and is number five for the highest stroke death rates. To combat this, the Arkansas Department of Health (ADH) and other healthcare…

Read More

Statewide Rx Take Back October 28

The Arkansas State Crime Laboratory and Medical Examiner’s Office report that hundreds of Arkansans died in 2016 from drug overdoses, with nearly 40 percent of those deaths from Pulaski, Sebastian, and Washington counties. Arkansas Attorney General Leslie Rutledge is encouraging Arkansans to clean out their medicine cabinets, and…

Read More

ADH Health Advisory

Rifampin/Penicillin-Resistant Strain of RB51 Brucella Contracted from Consumption of Raw Milk Summary: The Texas Department of State Health Services, with assistance from CDC, is investigating Brucella RB51 exposures and illnesses that may be connected to the purchase and consumption of raw (unpasteurized) milk from K-Bar Dairy in Paradise,…

Read More

CDC Health Advisory: Increase in Reported cases of Cyclospora cayetanensis Infection, United States, Summer 2017

Summary The Centers for Disease Control and Prevention (CDC), State and Local Health Departments, and the Food and Drug Administration (FDA) are investigating an increase in reported cases of cyclosporiasis. The purpose of this HAN Advisory is to notify public health departments and healthcare facilities and to provide guidance to healthcare…

Read More

CDC Health Advisory

Patients Receiving Eculizumab (Soliris®) at High Risk for Invasive Meningococcal Disease Despite Vaccination Summary Eculizumab (Soliris®) recipients have a 1,000 to 2,000-fold greater risk of invasive meningococcal disease compared to the general U.S. population. The Food and Drug Administration (FDA)-approved prescribing information for eculizumab includes a black box warning for…

Read More

Where’s My Doctor

"Where's my doctor?" We get that question a lot. It happens often when a physician leaves a practice, usually as an employee. Under most employment contracts the practice – either under hospital or physician ownership – retains ownership of the medical records when a physician leaves. However, the departing physician has a relationship with…

Read More

Misinformation Abounds on PDMP Mandate

The AMS office has received several calls over the past couple of weeks about Act 820, which mandates checking the Prescription Drug Monitoring Program prior to prescribing certain medications. Apparently, some hospitals are incorrectly telling their medical staff that the Act is already in effect. In other cases,…

Read More